Sector revisions Roche Holding AG Swiss Exchange

Equities

Market Closed - Swiss Exchange Other stock markets 16:30:36 15/05/2026 BST			5-day change	1st Jan Change
322.80 ^CHF	+0.88%		-0.59%	-1.65%

09:02pm	Fda approves Genentech's Tecentriq for adjuvant muscle-invasive bladder cancer with ctDNA-guided treatment	RE
05:47pm	FDA approves atezolizumab for adjuvant treatment of muscle invasive bladder cancer in some patients	RE

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							24
	ABBVIE INC.							29
	ASTRAZENECA PLC							21
	NOVARTIS AG							21
	MERCK & CO., INC.							27
	NOVO NORDISK A/S							23
	AMGEN INC.							30
	GILEAD SCIENCES, INC.							28
	PFIZER INC.							27
	BRISTOL-MYERS SQUIBB COMPANY							25
	VERTEX PHARMACEUTICALS INCORPORATED							28
	SANOFI							23
	GSK PLC							20
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	BAYER AG							19
	Average							23
	Weighted average by Cap.							25